APO Research, Inc.

APO RESEARCH · REPORT

Pharmaceuticals and Excipients

Selected research

Market Structure

Global Pharmaceuticals and Excipients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Pharmaceuticals and Excipients market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pharmaceuticals and Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceuticals and Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceuticals and Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pharmaceuticals and Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharmaceuticals and Excipients include Signet Chemical Corporation, Sigachi Industries, Shin-Etsu, Roquette, MEGGLE AG, Lubrizol, JRS Pharma, Evonik and ER-KANG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pharmaceuticals and Excipients market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceuticals and Excipients and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceuticals and Excipients sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharmaceuticals and Excipients market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceuticals and Excipients Segment by Company

Signet Chemical Corporation

Sigachi Industries

Shin-Etsu

Roquette

MEGGLE AG

Lubrizol

JRS Pharma

Evonik

ER-KANG

Dow

BASF

Ashland

ABITEC Corp

Pharmaceuticals and Excipients Segment by Type

Starch

Mannitol

Triglycerides

Dextrose

Sorbitol

Sucrose

Others

Pharmaceuticals and Excipients Segment by Application

Parenteral Formulations

Topical Formulations

Oral Formulations

Other

Pharmaceuticals and Excipients Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceuticals and Excipients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceuticals and Excipients and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceuticals and Excipients.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharmaceuticals and Excipients market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pharmaceuticals and Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pharmaceuticals and Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pharmaceuticals and Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pharmaceuticals and Excipients Industry Trends Table 2. Pharmaceuticals and Excipients Industry Drivers Table 3. Pharmaceuticals and Excipients Industry Opportunities and Challenges Table 4. Pharmaceuticals and Excipients Industry Restraints Table 5. Global Pharmaceuticals and Excipients Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pharmaceuticals and Excipients Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pharmaceuticals and Excipients Sales by Manufacturers (Tons) & (2021-2026) Table 8. Global Pharmaceuticals and Excipients Sales Market Share by Manufacturers Table 9. Global Pharmaceuticals and Excipients Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Pharmaceuticals and Excipients Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pharmaceuticals and Excipients Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pharmaceuticals and Excipients Manufacturers, Product Type & Application Table 13. Global Pharmaceuticals and Excipients Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharmaceuticals and Excipients by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Starch Table 17. Major Manufacturers of Mannitol Table 18. Major Manufacturers of Triglycerides Table 19. Major Manufacturers of Dextrose Table 20. Major Manufacturers of Sorbitol Table 21. Major Manufacturers of Sucrose Table 22. Major Manufacturers of Others Table 23. Global Pharmaceuticals and Excipients Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 24. Global Pharmaceuticals and Excipients Sales by Type (2021-2026) & (Tons) Table 25. Global Pharmaceuticals and Excipients Sales by Type (2027-2032) & (Tons) Table 26. Global Pharmaceuticals and Excipients Sales Market Share by Type (2021-2026) Table 27. Global Pharmaceuticals and Excipients Sales Market Share by Type (2027-2032) Table 28. Global Pharmaceuticals and Excipients Revenue by Type 2021 VS 2025 VS 2032 (Tons) Table 29. Global Pharmaceuticals and Excipients Revenue by Type (2021-2026) & (Tons) Table 30. Global Pharmaceuticals and Excipients Revenue by Type (2027-2032) & (Tons) Table 31. Global Pharmaceuticals and Excipients Revenue Market Share by Type (2021-2026) Table 32. Global Pharmaceuticals and Excipients Revenue Market Share by Type (2027-2032) Table 33. Major Manufacturers of Parenteral Formulations Table 34. Major Manufacturers of Topical Formulations Table 35. Major Manufacturers of Oral Formulations Table 36. Major Manufacturers of Other Table 37. Global Pharmaceuticals and Excipients Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 38. Global Pharmaceuticals and Excipients Sales by Application (2021-2026) & (Tons) Table 39. Global Pharmaceuticals and Excipients Sales by Application (2027-2032) & (Tons) Table 40. Global Pharmaceuticals and Excipients Sales Market Share by Application (2021-2026) Table 41. Global Pharmaceuticals and Excipients Sales Market Share by Application (2027-2032) Table 42. Global Pharmaceuticals and Excipients Revenue by Application 2021 VS 2025 VS 2032 (Tons) Table 43. Global Pharmaceuticals and Excipients Revenue by Application (2021-2026) & (Tons) Table 44. Global Pharmaceuticals and Excipients Revenue by Application (2027-2032) & (Tons) Table 45. Global Pharmaceuticals and Excipients Revenue Market Share by Application (2021-2026) Table 46. Global Pharmaceuticals and Excipients Revenue Market Share by Application (2027-2032) Table 47. Global Pharmaceuticals and Excipients Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 48. Global Pharmaceuticals and Excipients Sales by Region (2021-2026) & (Tons) Table 49. Global Pharmaceuticals and Excipients Sales Market Share by Region (2021-2026) Table 50. Global Pharmaceuticals and Excipients Sales Forecasted by Region (2027-2032) & (Tons) Table 51. Global Pharmaceuticals and Excipients Sales Forecasted Market Share by Region (2027-2032) Table 52. North America Pharmaceuticals and Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 53. North America Pharmaceuticals and Excipients Sales by Country (2021-2026) & (Tons) Table 54. North America Pharmaceuticals and Excipients Sales by Country (2027-2032) & (Tons) Table 55. Europe Pharmaceuticals and Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. Europe Pharmaceuticals and Excipients Sales by Country (2021-2026) & (Tons) Table 57. Europe Pharmaceuticals and Excipients Sales by Country (2027-2032) & (Tons) Table 58. Asia Pacific Pharmaceuticals and Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 59. Asia Pacific Pharmaceuticals and Excipients Sales by Country (2021-2026) & (Tons) Table 60. Asia Pacific Pharmaceuticals and Excipients Sales by Country (2027-2032) & (Tons) Table 61. South America, Middle East and Africa Pharmaceuticals and Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 62. South America, Middle East and Africa Pharmaceuticals and Excipients Sales by Country (2021-2026) & (Tons) Table 63. South America, Middle East and Africa Pharmaceuticals and Excipients Sales by Country (2027-2032) & (Tons) Table 64. Global Pharmaceuticals and Excipients Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Pharmaceuticals and Excipients Revenue by Region (2021-2026) & (US$ Million) Table 66. Global Pharmaceuticals and Excipients Revenue by Region (2027-2032) & (US$ Million) Table 67. Global Pharmaceuticals and Excipients Revenue Market Share by Region (2021-2026) Table 68. Global Pharmaceuticals and Excipients Revenue Market Share by Region (2027-2032) Table 69. Signet Chemical Corporation Company Information Table 70. Signet Chemical Corporation Business Overview Table 71. Signet Chemical Corporation Pharmaceuticals and Excipients Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Signet Chemical Corporation Pharmaceuticals and Excipients Product Portfolio Table 73. Signet Chemical Corporation Recent Development Table 74. Sigachi Industries Company Information Table 75. Sigachi Industries Business Overview Table 76. Sigachi Industries Pharmaceuticals and Excipients Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Sigachi Industries Pharmaceuticals and Excipients Product Portfolio Table 78. Sigachi Industries Recent Development Table 79. Shin-Etsu Company Information Table 80. Shin-Etsu Business Overview Table 81. Shin-Etsu Pharmaceuticals and Excipients Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Shin-Etsu Pharmaceuticals and Excipients Product Portfolio Table 83. Shin-Etsu Recent Development Table 84. Roquette Company Information Table 85. Roquette Business Overview Table 86. Roquette Pharmaceuticals and Excipients Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Roquette Pharmaceuticals and Excipients Product Portfolio Table 88. Roquette Recent Development Table 89. MEGGLE AG Company Information Table 90. MEGGLE AG Business Overview Table 91. MEGGLE AG Pharmaceuticals and Excipients Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. MEGGLE AG Pharmaceuticals and Excipients Product Portfolio Table 93. MEGGLE AG Recent Development Table 94. Lubrizol Company Information Table 95. Lubrizol Business Overview Table 96. Lubrizol Pharmaceuticals and Excipients Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Lubrizol Pharmaceuticals and Excipients Product Portfolio Table 98. Lubrizol Recent Development Table 99. JRS Pharma Company Information Table 100. JRS Pharma Business Overview Table 101. JRS Pharma Pharmaceuticals and Excipients Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. JRS Pharma Pharmaceuticals and Excipients Product Portfolio Table 103. JRS Pharma Recent Development Table 104. Evonik Company Information Table 105. Evonik Business Overview Table 106. Evonik Pharmaceuticals and Excipients Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Evonik Pharmaceuticals and Excipients Product Portfolio Table 108. Evonik Recent Development Table 109. ER-KANG Company Information Table 110. ER-KANG Business Overview Table 111. ER-KANG Pharmaceuticals and Excipients Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. ER-KANG Pharmaceuticals and Excipients Product Portfolio Table 113. ER-KANG Recent Development Table 114. Dow Company Information Table 115. Dow Business Overview Table 116. Dow Pharmaceuticals and Excipients Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Dow Pharmaceuticals and Excipients Product Portfolio Table 118. Dow Recent Development Table 119. BASF Company Information Table 120. BASF Business Overview Table 121. BASF Pharmaceuticals and Excipients Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. BASF Pharmaceuticals and Excipients Product Portfolio Table 123. BASF Recent Development Table 124. Ashland Company Information Table 125. Ashland Business Overview Table 126. Ashland Pharmaceuticals and Excipients Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Ashland Pharmaceuticals and Excipients Product Portfolio Table 128. Ashland Recent Development Table 129. ABITEC Corp Company Information Table 130. ABITEC Corp Business Overview Table 131. ABITEC Corp Pharmaceuticals and Excipients Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. ABITEC Corp Pharmaceuticals and Excipients Product Portfolio Table 133. ABITEC Corp Recent Development Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Pharmaceuticals and Excipients Distributors List Table 137. Pharmaceuticals and Excipients Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Pharmaceuticals and Excipients Product Image Figure 2. Global Pharmaceuticals and Excipients Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceuticals and Excipients Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceuticals and Excipients Sales (2021-2032) & (Tons) Figure 5. Global Pharmaceuticals and Excipients Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Pharmaceuticals and Excipients Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Starch Image Figure 9. Mannitol Image Figure 10. Triglycerides Image Figure 11. Dextrose Image Figure 12. Sorbitol Image Figure 13. Sucrose Image Figure 14. Others Image Figure 15. Global Pharmaceuticals and Excipients Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 16. Global Pharmaceuticals and Excipients Sales Market Share 2021 VS 2025 VS 2032 Figure 17. Global Pharmaceuticals and Excipients Sales Market Share by Type (2021-2032) Figure 18. Global Pharmaceuticals and Excipients Revenue by Type (2021 VS 2025 VS 2032) & (Tons) Figure 19. Global Pharmaceuticals and Excipients Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Pharmaceuticals and Excipients Revenue Market Share by Type (2021-2032) Figure 21. Parenteral Formulations Image Figure 22. Topical Formulations Image Figure 23. Oral Formulations Image Figure 24. Other Image Figure 25. Global Pharmaceuticals and Excipients Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 26. Global Pharmaceuticals and Excipients Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global Pharmaceuticals and Excipients Sales Market Share by Application (2021-2032) Figure 28. Global Pharmaceuticals and Excipients Revenue by Application (2021 VS 2025 VS 2032) & (Tons) Figure 29. Global Pharmaceuticals and Excipients Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global Pharmaceuticals and Excipients Revenue Market Share by Application (2021-2032) Figure 31. North America Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 32. North America Pharmaceuticals and Excipients Sales Market Share by Country (2021-2032) Figure 33. U.S. Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 34. Canada Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 35. Mexico Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 36. Europe Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 37. Europe Pharmaceuticals and Excipients Sales Market Share by Country (2021-2032) Figure 38. Germany Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 39. France Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 40. U.K. Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 41. Italy Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 42. Netherlands Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 43. Asia Pacific Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 44. Asia Pacific Pharmaceuticals and Excipients Sales Market Share by Country (2021-2032) Figure 45. China Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 46. Japan Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 47. South Korea Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 48. Southeast Asia Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 49. India Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 50. Australia Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 51. South America, Middle East and Africa Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 52. South America, Middle East and Africa Pharmaceuticals and Excipients Sales Market Share by Country (2021-2032) Figure 53. Brazil Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 54. South Africa Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 55. Saudi Arabia Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 56. Turkey Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 57. Argentina Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 58. UAE Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 59. Egypt Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 60. Chile Pharmaceuticals and Excipients Sales and Growth Rate (2021-2032) & (Tons) Figure 61. Global Pharmaceuticals and Excipients Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global Pharmaceuticals and Excipients Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Figure 64. North America Pharmaceuticals and Excipients Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Figure 66. Europe Pharmaceuticals and Excipients Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific Pharmaceuticals and Excipients Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa Pharmaceuticals and Excipients Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa Pharmaceuticals and Excipients Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. Pharmaceuticals and Excipients Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Pharmaceuticals and Excipients Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Starch
  • Mannitol
  • Triglycerides
  • Dextrose
  • Sorbitol
  • Sucrose
  • Others
Applications
  • Parenteral Formulations
  • Topical Formulations
  • Oral Formulations
  • Other
Companies covered
  • Signet Chemical Corporation
  • Sigachi Industries
  • Shin-Etsu
  • Roquette
  • MEGGLE AG
  • Lubrizol
  • JRS Pharma
  • Evonik
  • ER-KANG
  • Dow
  • BASF
  • Ashland
  • ABITEC Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceuticals and Excipients Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceuticals and Excipients Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pharmaceuticals and Excipients Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pharmaceuticals and Excipients Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pharmaceuticals and Excipients Market Dynamics
  1. 2.1 Pharmaceuticals and Excipients Industry Trends
  2. 2.2 Pharmaceuticals and Excipients Industry Drivers
  3. 2.3 Pharmaceuticals and Excipients Industry Opportunities and Challenges
  4. 2.4 Pharmaceuticals and Excipients Industry Restraints
3 Pharmaceuticals and Excipients Market by Manufacturers
  1. 3.1 Global Pharmaceuticals and Excipients Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pharmaceuticals and Excipients Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pharmaceuticals and Excipients Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pharmaceuticals and Excipients Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pharmaceuticals and Excipients Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pharmaceuticals and Excipients Manufacturers, Product Type & Application
  7. 3.7 Global Pharmaceuticals and Excipients Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pharmaceuticals and Excipients Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pharmaceuticals and Excipients Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pharmaceuticals and Excipients Tier 1, Tier 2, and Tier 3
4 Pharmaceuticals and Excipients Market by Type
  1. 4.1 Pharmaceuticals and Excipients Type Introduction
  2. 4.1.1 Starch
  3. 4.1.2 Mannitol
  4. 4.1.3 Triglycerides
  5. 4.1.4 Dextrose
  6. 4.1.5 Sorbitol
  7. 4.1.6 Sucrose
  8. 4.1.7 Others
  9. 4.2 Global Pharmaceuticals and Excipients Sales by Type
  10. 4.2.1 Global Pharmaceuticals and Excipients Sales by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Pharmaceuticals and Excipients Sales by Type (2021-2032)
  12. 4.2.3 Global Pharmaceuticals and Excipients Sales Market Share by Type (2021-2032)
  13. 4.3 Global Pharmaceuticals and Excipients Revenue by Type
  14. 4.3.1 Global Pharmaceuticals and Excipients Revenue by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Pharmaceuticals and Excipients Revenue by Type (2021-2032)
  16. 4.3.3 Global Pharmaceuticals and Excipients Revenue Market Share by Type (2021-2032)
5 Pharmaceuticals and Excipients Market by Application
  1. 5.1 Pharmaceuticals and Excipients Application Introduction
  2. 5.1.1 Parenteral Formulations
  3. 5.1.2 Topical Formulations
  4. 5.1.3 Oral Formulations
  5. 5.1.4 Other
  6. 5.2 Global Pharmaceuticals and Excipients Sales by Application
  7. 5.2.1 Global Pharmaceuticals and Excipients Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pharmaceuticals and Excipients Sales by Application (2021-2032)
  9. 5.2.3 Global Pharmaceuticals and Excipients Sales Market Share by Application (2021-2032)
  10. 5.3 Global Pharmaceuticals and Excipients Revenue by Application
  11. 5.3.1 Global Pharmaceuticals and Excipients Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Pharmaceuticals and Excipients Revenue by Application (2021-2032)
  13. 5.3.3 Global Pharmaceuticals and Excipients Revenue Market Share by Application (2021-2032)
6 Global Pharmaceuticals and Excipients Sales by Region
  1. 6.1 Global Pharmaceuticals and Excipients Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceuticals and Excipients Sales by Region (2021-2032)
  3. 6.2.1 Global Pharmaceuticals and Excipients Sales by Region (2021-2026)
  4. 6.2.2 Global Pharmaceuticals and Excipients Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceuticals and Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pharmaceuticals and Excipients Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pharmaceuticals and Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pharmaceuticals and Excipients Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pharmaceuticals and Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pharmaceuticals and Excipients Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pharmaceuticals and Excipients Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pharmaceuticals and Excipients Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pharmaceuticals and Excipients Revenue by Region
  1. 7.1 Global Pharmaceuticals and Excipients Revenue by Region
  2. 7.1.1 Global Pharmaceuticals and Excipients Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pharmaceuticals and Excipients Revenue by Region (2021-2026)
  4. 7.1.3 Global Pharmaceuticals and Excipients Revenue by Region (2027-2032)
  5. 7.1.4 Global Pharmaceuticals and Excipients Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pharmaceuticals and Excipients Revenue (2021-2032)
  8. 7.2.2 North America Pharmaceuticals and Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pharmaceuticals and Excipients Revenue (2021-2032)
  11. 7.3.2 Europe Pharmaceuticals and Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pharmaceuticals and Excipients Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pharmaceuticals and Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pharmaceuticals and Excipients Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pharmaceuticals and Excipients Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Signet Chemical Corporation
  2. 8.1.1 Signet Chemical Corporation Company Information
  3. 8.1.2 Signet Chemical Corporation Business Overview
  4. 8.1.3 Signet Chemical Corporation Pharmaceuticals and Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Signet Chemical Corporation Pharmaceuticals and Excipients Product Portfolio
  6. 8.1.5 Signet Chemical Corporation Recent Developments
  7. 8.2 Sigachi Industries
  8. 8.2.1 Sigachi Industries Company Information
  9. 8.2.2 Sigachi Industries Business Overview
  10. 8.2.3 Sigachi Industries Pharmaceuticals and Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sigachi Industries Pharmaceuticals and Excipients Product Portfolio
  12. 8.2.5 Sigachi Industries Recent Developments
  13. 8.3 Shin-Etsu
  14. 8.3.1 Shin-Etsu Company Information
  15. 8.3.2 Shin-Etsu Business Overview
  16. 8.3.3 Shin-Etsu Pharmaceuticals and Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shin-Etsu Pharmaceuticals and Excipients Product Portfolio
  18. 8.3.5 Shin-Etsu Recent Developments
  19. 8.4 Roquette
  20. 8.4.1 Roquette Company Information
  21. 8.4.2 Roquette Business Overview
  22. 8.4.3 Roquette Pharmaceuticals and Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Roquette Pharmaceuticals and Excipients Product Portfolio
  24. 8.4.5 Roquette Recent Developments
  25. 8.5 MEGGLE AG
  26. 8.5.1 MEGGLE AG Company Information
  27. 8.5.2 MEGGLE AG Business Overview
  28. 8.5.3 MEGGLE AG Pharmaceuticals and Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 MEGGLE AG Pharmaceuticals and Excipients Product Portfolio
  30. 8.5.5 MEGGLE AG Recent Developments
  31. 8.6 Lubrizol
  32. 8.6.1 Lubrizol Company Information
  33. 8.6.2 Lubrizol Business Overview
  34. 8.6.3 Lubrizol Pharmaceuticals and Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lubrizol Pharmaceuticals and Excipients Product Portfolio
  36. 8.6.5 Lubrizol Recent Developments
  37. 8.7 JRS Pharma
  38. 8.7.1 JRS Pharma Company Information
  39. 8.7.2 JRS Pharma Business Overview
  40. 8.7.3 JRS Pharma Pharmaceuticals and Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 JRS Pharma Pharmaceuticals and Excipients Product Portfolio
  42. 8.7.5 JRS Pharma Recent Developments
  43. 8.8 Evonik
  44. 8.8.1 Evonik Company Information
  45. 8.8.2 Evonik Business Overview
  46. 8.8.3 Evonik Pharmaceuticals and Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Evonik Pharmaceuticals and Excipients Product Portfolio
  48. 8.8.5 Evonik Recent Developments
  49. 8.9 ER-KANG
  50. 8.9.1 ER-KANG Company Information
  51. 8.9.2 ER-KANG Business Overview
  52. 8.9.3 ER-KANG Pharmaceuticals and Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 ER-KANG Pharmaceuticals and Excipients Product Portfolio
  54. 8.9.5 ER-KANG Recent Developments
  55. 8.10 Dow
  56. 8.10.1 Dow Company Information
  57. 8.10.2 Dow Business Overview
  58. 8.10.3 Dow Pharmaceuticals and Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Dow Pharmaceuticals and Excipients Product Portfolio
  60. 8.10.5 Dow Recent Developments
  61. 8.11 BASF
  62. 8.11.1 BASF Company Information
  63. 8.11.2 BASF Business Overview
  64. 8.11.3 BASF Pharmaceuticals and Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 BASF Pharmaceuticals and Excipients Product Portfolio
  66. 8.11.5 BASF Recent Developments
  67. 8.12 Ashland
  68. 8.12.1 Ashland Company Information
  69. 8.12.2 Ashland Business Overview
  70. 8.12.3 Ashland Pharmaceuticals and Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Ashland Pharmaceuticals and Excipients Product Portfolio
  72. 8.12.5 Ashland Recent Developments
  73. 8.13 ABITEC Corp
  74. 8.13.1 ABITEC Corp Company Information
  75. 8.13.2 ABITEC Corp Business Overview
  76. 8.13.3 ABITEC Corp Pharmaceuticals and Excipients Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 ABITEC Corp Pharmaceuticals and Excipients Product Portfolio
  78. 8.13.5 ABITEC Corp Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharmaceuticals and Excipients Value Chain Analysis
  2. 9.1.1 Pharmaceuticals and Excipients Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharmaceuticals and Excipients Production Mode & Process
  6. 9.2 Pharmaceuticals and Excipients Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharmaceuticals and Excipients Distributors
  9. 9.2.3 Pharmaceuticals and Excipients Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.